Janux Therapeutics
Cuiling Yu is a Principal Scientist at Janux Therapeutics, where Cuiling is involved in the discovery of bispecific therapeutics. Prior to their current role, Yu held positions at BioLegend as a Senior Scientist, focusing on recombinant antibody product development and manufacturing, and at Emory University School of Medicine as a Research Associate. Cuiling holds a Ph.D. in Biochemistry, Immunology, and Molecular Biology from Sun Yat-sen University and has completed a Certificate Program in Clinical and Translational Research from Emory University.
This person is not in the org chart
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.